NIOX Group (LON:NIOX) Stock Price Up 2% – What’s Next?

NIOX Group Plc (LON:NIOX)’s stock price traded up 2% on Wednesday . The stock traded as high as GBX 63 and last traded at GBX 62.40. Approximately 696,601 shares changed hands during trading, a decline of 20% from the average daily volume of 868,340 shares. The stock had previously closed at GBX 61.20.

NIOX Group Trading Down 1.6%

The business’s 50 day simple moving average is GBX 59.35 and its 200 day simple moving average is GBX 61.22. The stock has a market cap of £261.78 million, a price-to-earnings ratio of 37.93 and a beta of 0.92. The company has a quick ratio of 1.94, a current ratio of 3.81 and a debt-to-equity ratio of 1.36.

Insider Activity at NIOX Group

In other news, insider Sarah Duncan sold 34,219 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of GBX 58, for a total value of £19,847.02. 5.11% of the stock is currently owned by corporate insiders.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.